Biospecimens. If Collaborator possesses any human Biospecimens from clinical trials under the CRADA, the Biospecimens must be handled as described in the Protocol or as otherwise directed by NCI before the termination date of the CRADA.
Appears in 2 contracts
Sources: Cooperative Research and Development Agreement, Cooperative Research and Development Agreement